Literature DB >> 24269487

Right atrium cholinergic deficit in septic rats.

Paola Contreras1, Eduardo R Migliaro2, Bruno Suhr2.   

Abstract

Heart rate variability (HRV) is mainly determined by the influence of both branches of the Autonomic Nervous System over the sinus node. Low HRV has been associated with a worse prognosis in patients with sepsis. The objective of this study was to explain the reduction in HRV during experimental sepsis in adult rats. We recorded the heart's electrical activity by telemetry in conscious unrestrained male rats before and 1day after the induction of peritonitis (N=39) or sham peritonitis (N=15). Then, we analyzed the chronotropic responsiveness of the isolated heart to the autonomic neurotransmitters and determined catecholamine concentrations in blood plasma and acetylcholine and choline concentrations in the right atrium. The surviving septic rats (N=33) had increased heart rate (HR) and diminished HRV. Despite the higher HR in situ, the spontaneous basal HR in septic and sham isolated hearts was the same. The isolated septic hearts showed acetylcholine hypersensitivity (log (IC50,M)=-7.2±0.2 vs. -6.0±0.4, P=0.025) and lower concentrations of choline in their right atriums (in nMol/mg protein: 0.6±0.1 vs. 1.6±0.6, P=0.013). Norepinephrine concentration in blood plasma from septic rats was higher (in ng/ml: 29.2±8.4 vs. 5.8±4.1, P=0.019). In conclusion, septic rats present a deregulation of the autonomic nervous system, not only sympathetic overexcitation but also parasympathetic dysfunction.
© 2013.

Entities:  

Keywords:  Autonomic dysfunction; Heart rate variability; Sepsis; Telemetry

Mesh:

Substances:

Year:  2013        PMID: 24269487     DOI: 10.1016/j.autneu.2013.10.002

Source DB:  PubMed          Journal:  Auton Neurosci        ISSN: 1566-0702            Impact factor:   3.145


  2 in total

1.  Phospholamban ablation rescues the enhanced propensity to arrhythmias of mice with CaMKII-constitutive phosphorylation of RyR2 at site S2814.

Authors:  G Mazzocchi; L Sommese; J Palomeque; J I Felice; M N Di Carlo; D Fainstein; P Gonzalez; P Contreras; D Skapura; M D McCauley; E C Lascano; J A Negroni; E G Kranias; X H T Wehrens; C A Valverde; A Mattiazzi
Journal:  J Physiol       Date:  2016-02-02       Impact factor: 5.182

2.  Benefits in cardiac function by CD38 suppression: Improvement in NAD+ levels, exercise capacity, heart rate variability and protection against catecholamine-induced ventricular arrhythmias.

Authors:  Guillermo Agorrody; Thais R Peclat; Gonzalo Peluso; Luis A Gonano; Leonardo Santos; Wim van Schooten; Claudia C S Chini; Carlos Escande; Eduardo N Chini; Paola Contreras
Journal:  J Mol Cell Cardiol       Date:  2022-02-01       Impact factor: 5.763

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.